IS4164A - Efnasambönd sem hindra flæði magasýru - Google Patents

Efnasambönd sem hindra flæði magasýru

Info

Publication number
IS4164A
IS4164A IS4164A IS4164A IS4164A IS 4164 A IS4164 A IS 4164A IS 4164 A IS4164 A IS 4164A IS 4164 A IS4164 A IS 4164A IS 4164 A IS4164 A IS 4164A
Authority
IS
Iceland
Prior art keywords
pct
gastric acid
compounds
acid flow
inhibit gastric
Prior art date
Application number
IS4164A
Other languages
English (en)
Inventor
Ingemar Starke Carl
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9302005A external-priority patent/SE9302005D0/xx
Priority claimed from SE9303970A external-priority patent/SE9303970D0/xx
Application filed by Ab Astra filed Critical Ab Astra
Publication of IS4164A publication Critical patent/IS4164A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
IS4164A 1993-06-11 1994-05-11 Efnasambönd sem hindra flæði magasýru IS4164A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9302005A SE9302005D0 (sv) 1993-06-11 1993-06-11 New active compounds
SE9303970A SE9303970D0 (sv) 1993-11-30 1993-11-30 New active compounds

Publications (1)

Publication Number Publication Date
IS4164A true IS4164A (is) 1994-12-12

Family

ID=26661770

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4164A IS4164A (is) 1993-06-11 1994-05-11 Efnasambönd sem hindra flæði magasýru

Country Status (25)

Country Link
US (1) US5889021A (is)
EP (1) EP0702672B1 (is)
JP (1) JP3623794B2 (is)
CN (1) CN1045955C (is)
AT (1) ATE196134T1 (is)
AU (1) AU680516B2 (is)
BR (1) BR9406772A (is)
CA (1) CA2164875A1 (is)
CZ (1) CZ326095A3 (is)
DE (1) DE69425823T2 (is)
EE (1) EE03123B1 (is)
EG (1) EG20435A (is)
ES (1) ES2150494T3 (is)
FI (1) FI955896A0 (is)
HU (1) HUT75122A (is)
IL (1) IL109685A (is)
IS (1) IS4164A (is)
NO (1) NO305799B1 (is)
NZ (1) NZ267740A (is)
PL (1) PL177766B1 (is)
RU (1) RU2142454C1 (is)
SG (1) SG47820A1 (is)
SK (1) SK154995A3 (is)
TW (1) TW261613B (is)
WO (1) WO1994029274A1 (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
AU2002950217A0 (en) 2002-07-16 2002-09-12 Prana Biotechnology Limited 8- Hydroxy Quinoline Derivatives
JP6659850B2 (ja) * 2015-12-31 2020-03-04 シャンハイ ファーマシューティカルズ ホールディング カンパニー，リミティド キノリン系化合物の塩、その結晶形、調製方法、組成物及び用途

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US509804A (en) * 1893-11-28 Hoof-weight
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
US4042702A (en) * 1973-08-16 1977-08-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Halogen pyrazole derivatives, a method for producing these halogen pyrazole derivatives, medicaments containing and methods of using them
LU69428A1 (is) * 1974-02-20 1975-12-09
US4120966A (en) * 1975-02-03 1978-10-17 Smith Kline & French Laboratories Limited Heterocyclic-methylthioethyl-dithiocarbamates and isothioureas
NO760996L (is) * 1975-03-25 1976-09-28 Byk Gulden Lomberg Chem Fab
AT364354B (de) * 1976-10-14 1981-10-12 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von neuen pyrazol-1yl-phenylessigsaeuren, deren salzen und optischen isomeren
LU78804A1 (de) * 1977-12-30 1979-07-20 Byk Gulden Lomberg Chem Fab N-substituierte w-aminoalkanoyl-w-aminoalkansaeuren,ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US4243678A (en) * 1977-12-30 1981-01-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Acylhydrocarbylaminoalkanoic acids, compositions and uses
YU118379A (en) * 1978-05-24 1983-02-28 Byk Gulden Lomberg Chemischefa Process for preparing phenylaminothiophene acetic acid
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
DK334580A (da) * 1979-08-03 1981-02-04 Byk Gulden Lomberg Chem Fab Fremgangsmaade til fremstilling af substituerede tetraazatricycler
EP0024638A1 (en) * 1979-08-30 1981-03-11 Byk Gulden Lomberg Chemische Fabrik GmbH Substituted quinolinone-alkanecarboxylic acids, their preparation, and medicaments containing them
ATE3291T1 (de) * 1979-09-07 1983-05-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituierte oxirancarbonsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel.
ES496382A0 (es) * 1979-10-31 1982-03-01 Byk Gulden Lomberg Chem Fab Procedimiento para la preparacion de acidos oxocarboxilicos sustituidos
US4381301A (en) * 1980-05-07 1983-04-26 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted tricyclic thieno compounds, their synthesis, their use, their compositions and their medicaments
US4337267A (en) * 1980-08-25 1982-06-29 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenalkoxyalkyl- and phenoxyalkyl-substituted oxiranecarboxylic acids, their use and medicaments containing them
WO1982000822A1 (en) * 1980-08-29 1982-03-18 Eistetter K Substituted oxiranecarboxylic acids,their preparation and their use as medicaments
DE3262922D1 (en) * 1981-02-02 1985-05-15 Byk Gulden Lomberg Chem Fab Tricyclic pyrrols, process for their preparation, their use and compositions containing them
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
EP0187977B1 (en) * 1984-12-18 1990-08-29 Otsuka Pharmaceutical Co., Ltd. Tetrahydroquinoline derivatives, process for preparing the same and anti-peptic ulcer compositions containg the same
US5250527A (en) * 1985-10-24 1993-10-05 Smithkline & French Laboratories Limited Pyridyl containing benzimidazoles, compositions and use
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8717644D0 (en) * 1987-07-24 1987-09-03 Smithkline Beckman Intercredit Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5049567A (en) * 1988-02-25 1991-09-17 Smithkline Beckman Intercredit B.V. Substituted 4-aminoquinazoline derivatives and method of use
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
GB8908229D0 (en) * 1989-04-12 1989-05-24 Smithkline Beckman Intercredit Compounds
GB8910722D0 (en) * 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
JPH04211661A (ja) * 1990-03-28 1992-08-03 Otsuka Pharmaceut Co Ltd キノリン誘導体及び該誘導体を含有する抗潰瘍剤
HUT67609A (en) * 1991-01-29 1995-04-28 Smithkline Beecham Intercredit Salts of a 4-amino-3-acyl-quinoline derivative, their preparation and pharmaceutical compositions comprising them
GB9126438D0 (en) * 1991-12-12 1992-02-12 Smithkline Beecham Intercredit New quinoline derivatives

Also Published As

Publication number Publication date
EP0702672B1 (en) 2000-09-06
CA2164875A1 (en) 1994-12-22
ES2150494T3 (es) 2000-12-01
NO954928L (no) 1995-12-05
PL177766B1 (pl) 2000-01-31
BR9406772A (pt) 1996-02-21
TW261613B (is) 1995-11-01
WO1994029274A1 (en) 1994-12-22
HUT75122A (en) 1997-04-28
CN1045955C (zh) 1999-10-27
NZ267740A (en) 1997-05-26
HU9503529D0 (en) 1996-02-28
EE03123B1 (et) 1998-10-15
AU680516B2 (en) 1997-07-31
JP3623794B2 (ja) 2005-02-23
EP0702672A1 (en) 1996-03-27
DE69425823T2 (de) 2001-01-18
CZ326095A3 (en) 1996-05-15
IL109685A0 (en) 1994-11-28
FI955896A (fi) 1995-12-08
SG47820A1 (en) 1998-04-17
IL109685A (en) 1999-03-12
DE69425823D1 (de) 2000-10-12
JPH09510951A (ja) 1997-11-04
US5889021A (en) 1999-03-30
CN1125438A (zh) 1996-06-26
PL311957A1 (en) 1996-03-18
SK154995A3 (en) 1996-09-04
FI955896A0 (fi) 1995-12-08
NO954928D0 (no) 1995-12-05
NO305799B1 (no) 1999-07-26
RU2142454C1 (ru) 1999-12-10
EG20435A (en) 1999-04-29
ATE196134T1 (de) 2000-09-15
AU7012194A (en) 1995-01-03

Similar Documents

Publication Publication Date Title
TW515798B (en) Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
SE9801526D0 (sv) New compounds
MY118822A (en) Compounds for inhibition of gastric acid secretion
DK0683780T3 (da) Imidazopyridiner og deres anvendelse til behandling af mave-tarm-sygdomme
MY119012A (en) New compounds
SE9802794D0 (sv) New compounds
SE9802793D0 (sv) New compounds
MXPA04001402A (es) Compuestos de imidazopiridina novedosos con efecto terapeutico.
PL329413A1 (en) Chemical compounds exhibiting properties capable to cause growth hormone release
IS4164A (is) Efnasambönd sem hindra flæði magasýru
MX9704136A (es) Compuestos para la inhibicion de la secrecion de acido gastrico.
SE9302005D0 (sv) New active compounds